Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
about
The effect of statins on average survival in randomised trials, an analysis of end point postponementThe effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represDrugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.Distribution of lifespan gain from primary prevention intervention.Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.Cholesterol trials and mortality.Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators.New metrics needed to visualize the long-term impact of early LDL-C lowering on the cardiovascular disease trajectory.Men and women--similar but not identical: insights into LDL-lowering therapy in women from the Cholesterol Treatment Trialists Collaboration.A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies.NORRISK 2: A Norwegian risk model for acute cerebral stroke and myocardial infarction.Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups.Need for hyperlipidemia management policy reform in China: learning from the global experience.Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.Lifelong benefits on myocardial infarction mortality: 40-year follow-up of the randomized Oslo diet and antismoking study.Legacy effect of statins: 20-year follow up of the West of Scotland Coronary Prevention Study (WOSCOPS).Investigating the long-term legacy of statin therapy.A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States.Delineating the Interplay of Personality Disorders and Health.Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.Cholesterol-lowering drugs: science and marketing.Cardiovascular diseases in Brazil: premature mortality, risk factors and priorities for action. Comments on the preliminary results from the Brazilian National Health Survey (PNS), 20132016 European Guidelines on cardiovascular disease prevention in clinical practice
P2860
Q26786733-2C3C65DA-6F6C-4E50-80D8-3721DA1BE06BQ30914775-17002DA4-38F9-4592-BB2D-604A80CD7ED7Q34046881-46E6B540-879E-4F22-9CBE-2CD290EE5FC1Q36082805-8E6062B7-5D83-459E-BEAA-0CE0FC7BA969Q36107244-9F596D3A-9A47-421E-AC00-C9143029533FQ36709175-DF41F977-9DEA-4FFB-A7AD-53C31702FDD4Q36973367-9D5A4E96-AB4A-47C5-A812-06ECDA919571Q37030666-705F8342-27EB-4887-B089-8D846F2CA838Q37722982-ADDC0D8D-14E5-48E1-944F-A35E2C6D8577Q38427745-44CC2C3E-C20A-4754-B501-AF2ADF60CF68Q38592760-93EB373E-4C54-4BE3-9ADA-EB2CA8DE8B1BQ38754290-23BB646F-C522-45F8-9181-DBB920A87741Q38958016-AF7A428D-D449-473F-8ED6-18FB866E73E4Q38991225-131FE91F-E45C-4E57-AD35-B1A1CAE3BF65Q39428465-3DC43465-E40B-41F8-A07B-6130D46179E8Q40397890-E7EA9501-51E1-4D4C-9D74-1349AEFBC194Q40882176-10C12B95-9B53-4895-AE2D-6D8B4E2FC487Q42287723-46FE51A2-D70A-49C2-81D2-198717FB7261Q42354902-40DE278A-60DB-430B-8FC6-DD3D9AD735DDQ45061743-F74BC17A-E02F-43F5-8BC2-C0F77E9BB080Q46192442-B1679A34-234F-4BF0-9F94-5A37280A0408Q47801493-49DDA3B9-6E12-4482-A748-04DE1F4DD8C1Q51193262-F8045BC5-0BA5-488B-9062-485C98F3F8CFQ56785950-61E55A1E-484E-4FD5-9D37-6C744DA072B5Q56991525-6C64A71C-F08C-405D-AD29-A527F48E7A34
P2860
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-term impact on healthcare ...... isease: a record linkage study
@ast
Long-term impact on healthcare ...... isease: a record linkage study
@en
Long-term impact on healthcare ...... isease: a record linkage study
@nl
type
label
Long-term impact on healthcare ...... isease: a record linkage study
@ast
Long-term impact on healthcare ...... isease: a record linkage study
@en
Long-term impact on healthcare ...... isease: a record linkage study
@nl
prefLabel
Long-term impact on healthcare ...... isease: a record linkage study
@ast
Long-term impact on healthcare ...... isease: a record linkage study
@en
Long-term impact on healthcare ...... isease: a record linkage study
@nl
P2093
P2860
P3181
P356
P1476
Long-term impact on healthcare ...... isease: a record linkage study
@en
P2093
Alex McConnachie
Andrew Walker
Christopher J Packard
Julie Peacock
Laura Marchbank
Michele Robertson
Stuart M Cobbe
P2860
P3181
P356
10.1093/EURHEARTJ/EHT232
P407
P577
2014-02-01T00:00:00Z